Bioaffinity Technologies Inc (BIAF)

Jun 15, 2026

bioAffinity Technologies Warrant (BIAFW) Holds Steady at $0.16 as Trading Remains QuietRevenue Weighted - newsline.com

Jun 15, 2026

Jun 14, 2026

BIAF Q3 2025 Earnings: Wider-than-Expected Loss Misses EstimatesEarnings Miss Streak - newsline.com

Jun 14, 2026

Jun 13, 2026

BioAffinity Technologies Files to Offer 2.63M Shrs or Pre-Funded Warrants - Moomoo

Jun 13, 2026

Jun 12, 2026

BIAF News | BIOAFFINITY TECHNOLOGIES INC (NASDAQ:BIAF) - ChartMill

Jun 12, 2026

Jun 12, 2026

Bioaffinity TechnologiesOffers 2.63 Million Shares Of Common StockSEC Filing - TradingView

Jun 12, 2026

Jun 12, 2026

[S-1] bioAffinity Technologies, Inc. Files IPO Registration Statement - Stock Titan

Jun 12, 2026

Jun 12, 2026

BIAFW Holds Steady Amid Warrant Market Uncertainty: Support and Resistance in Tight RangeElliott Wave Entry - newsline.com

Jun 12, 2026

Jun 08, 2026

bioAffinity Technologies, Inc. - MLQ.ai

Jun 08, 2026

Jun 05, 2026

BIAF Stock Chart | BIOAFFINITY TECHNOLOGIES INC (NASDAQ:BIAF) - ChartMill

Jun 05, 2026

Jun 04, 2026

bioAffinity Technologies Stock Draws Fresh Attention From Traders - Bez Kabli

Jun 04, 2026

Jun 02, 2026

Multidisciplinary Physician Panel to Share Real-World Benefits of bioAffinity Technologies’ Noninvasive CyPath Lung Cancer Test in Upcoming Society for Advanced Bronchoscopy Webinar - BioSpace

Jun 02, 2026

Jun 02, 2026

bioAffinity Showcases CyPath Lung in Upcoming Clinical Webinar - TipRanks

Jun 02, 2026

Jun 02, 2026

bioAffinity webinar to showcase CyPath Lung's role in early-stage lung cancer detection - TradingView

Jun 02, 2026

Jun 02, 2026

bioAffinity Technologies (BIAF) spotlights CyPath Lung test in SAB lung cancer webinar - Stock Titan

Jun 02, 2026

May 30, 2026

BIAF Q3 2025 Earnings: Wider-than-Expected Loss as Pre-Revenue Biotech Continues DevelopmentManagement Guidance Update - thelegaladvocate.com

May 30, 2026

May 29, 2026

bioAffinity Technologies (BIAF) Edges Higher Amidst Support Test – Potential for BreakoutGap Down Bounce Plays - newsline.com

May 29, 2026

May 29, 2026

BIAFW Warrants Trade Flat Near Support Amidst Quiet Market ConditionsEntry Point Alerts - newsline.com

May 29, 2026

May 28, 2026

bioAffinity Technologies (BIAF) Holds Steady at $1.65 as Consolidation PersistsTechnical Analysis Picks - newsline.com

May 28, 2026

May 27, 2026

bioAffinity receives patent allowance in Mexico for lung test - Investing.com UK

May 27, 2026

May 27, 2026

bioAffinity Technologies Announces Notification of Mexico Patent Allowance Covering Novel Lung Cancer Detection Methods Using CyPath® Lung Technology - BioSpace

May 27, 2026

May 27, 2026

bioAffinity receives patent allowance in Mexico for lung test By Investing.com - Investing.com Nigeria

May 27, 2026

May 27, 2026

bioAffinity Technologies notifies Mexico patent allowance for CyPath® Lung flow cytometry method - TradingView

May 27, 2026

May 27, 2026

Mexico backs bioAffinity (NASDAQ: BIAF) patent on CyPath Lung test - Stock Titan

May 27, 2026

May 27, 2026

bioAffinity Gains Mexican Patent for CyPath Lung Diagnostic - TipRanks

May 27, 2026

May 26, 2026

bioAffinity Technologies (BIAF) News Flow - Moomoo

May 26, 2026

May 24, 2026

Number of shareholders of bioAffinity Technologies, Inc. – NASDAQ:BIAF - TradingView

May 24, 2026

May 22, 2026

BIAF Q3 2025 Earnings: EPS Misses Estimates Amid No Revenue, Stock DeclinesEarnings Miss Streak - newsline.com

May 22, 2026

May 21, 2026

What's Driving bioAffinity Technologies' Recent Surge - Kavout

May 21, 2026

May 20, 2026

Top AIAI (AIAI) Competitors 2026 - MarketBeat

May 20, 2026

May 15, 2026

bioAffinity Technologies Inc (BIAF) Stock Price, Quote, News & History - Benzinga

May 15, 2026

May 15, 2026

BIAF Stock Price, Quote & Chart | BIOAFFINITY TECHNOLOGIES INC (NASDAQ:BIAF) - ChartMill

May 15, 2026

May 14, 2026

bioAffinity (BIAF) registers 497,483 resale shares, includes 365,603 warrants - Stock Titan

May 14, 2026

May 14, 2026

BIAF Stock Slips Post Q1 Earnings Despite Strength in CyPath Lung - The Globe and Mail

May 14, 2026

May 13, 2026

[EFFECT] bioAffinity Technologies, Inc. SEC Filing - Stock Titan

May 13, 2026

May 12, 2026

bioAffinity reports 300% jump in lung test sales in April - Investing.com UK

May 12, 2026

May 12, 2026

bioAffinity Technologies Reports Record Monthly CyPath® Lung Unit Sales and Significant Year-Over-Ye - PharmiWeb.com

May 12, 2026

May 12, 2026

bioAffinity Technologies Reports Record Monthly CyPath® Lung Unit Sales and Significant Year-Over-Year Growth in April 2026 - 01net

May 12, 2026

May 12, 2026

bioAffinity Technologies Reports Record 300% Growth in CyPath® Lung Diagnostic Test Sales in April 2026 - Minichart

May 12, 2026

May 12, 2026

bioAffinity CyPath Lung Test Sales Surge Sharply - TipRanks

May 12, 2026

May 12, 2026

TradingKey - TradingKey

May 12, 2026

May 12, 2026

bioAffinity reports 300% jump in lung test sales in April By Investing.com - Investing.com Australia

May 12, 2026

May 12, 2026

bioAffinity Reports Record Monthly CyPath Lung Unit Sales, April Up Nearly 300% - TradingView

May 12, 2026

May 12, 2026

Record CyPath Lung growth at bioAffinity (NASDAQ: BIAF) with April unit sales up nearly 300% - Stock Titan

May 12, 2026

May 11, 2026

bioAffinity Technologies, Inc. 2026 Q1 10-Q Filing: Financial Results, Risk Factors, and Forward-Looking Statements - Minichart

May 11, 2026

May 11, 2026

bioAffinity Technologies reports net loss of USD 3.6M in Q1 2026 - Medical Buyer

May 11, 2026